Jansen's metaphyseal chondrodysplasia: A disorder due to a PTH/PTHrP receptor gene mutation

Trends in Endocrinology and Metabolism

Volumn 7, Issue 5, 1996, Pages 157-162

  Jüppner, Harald ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIC AMP; DNA; MINERAL; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR;

CALCIUM HOMEOSTASIS; CARTILAGE CELL; CHONDRODYSPLASIA; GENE MUTATION; GROWTH PLATE; HUMAN; HYPERCALCEMIA; METAPHYSIS; MINERAL BALANCE; MISSENSE MUTATION; PRIORITY JOURNAL; RECEPTOR GENE; REVIEW; SHORT LIMBED DWARFISM;

EID: 0030199951     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(96)00063-X     Document Type: Short Survey

References (48)

1. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC: 1994, Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondreal bone formation. J Cell Biol 126:1611-1623.
2. Arroyo-Scotoliff H: 1973. Metaphyseal dysostosis, Jansen type. J Bone Joint Surg 55A:623-629.
3. Broadus AE, Stewart AF: 1994. Parathyroid hormone-related protein: Structure, processing, and physiological actions. In Bilezikian JP, Levine MA, Marcus R, eds. The Parathyroids. Basic and Clinical Concepts. New York, Raven Press, pp 259-294.
4. Cameron JAP, Young WB, Sissons HA: 1954. Metaphysial dysostosis: report of a case. J Bone Joint Surg 36B:622-629.
5. Charrow J, Poznanski AK: 1984. The Jansen type of metaphyseal chondrodysplasia: conformation of dominant inheritance and review of radiographic manifestations in the newborn and adult. J Med Genet 18:321-327.
6. De Haas WHD, De Boer W, Griffioen F: 1969. Metaphysial dysostosis: a late follow-up of the first reported case. J Bone Joint Surg 51B:290-299.
7. Dryja TP, Berson EL, Rao VR, Oprian DD: 1993. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet 4:280-283.
8. Duprez L, Parma J, Van Sande J, et al.: 1994. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7: 396-401.
9. Frame B, Poznanski AK: 1980. Conditions that may be confused with rickets. In DeLuca HF, Anast CS, eds. Pediatric Diseases Related to Calcium. New York, Elsevier, pp 269-289.
10. Gram PB, Fleming JL, Frame B, Fine G: 1959. Metaphyseal chondrodysplasia of Jansen. J Bone Joint Surg 41A:951-959.
11. Holt JF: 1969. Skeletal dysplasias. In Bergsma D, ed. The Clinical Delineation of Birth Defects. Baltimore, MD, The National Foundation-March of Dimes, pp 73-75.
12. Holthusen W, Holt JF, Stoeckenius M. 1975. The skull in metaphyseal chondrodysplasia type Jansen. Pediatr Radiol 3:137-144.
13. Iwamoto M, Jikko A, Murakami H, et al.: 1994. Changes in parathyroid hormone receptors during chondrocyte cytodifferentiation. J Biol Chem 269:17,245-17,251.
14. Jaffe HL: 1972. Metabolic, Degenerative, and Inflammatory Diseases of Bones and Joints. Philadelphia, Lea and Febiger.
15. Jansen M: 1934. Über atypische Chondrodystrophie (Achondroplasie) und über eine noch nicht beschriebene angeborene Wachstumsstörung des Knochensystems: metaphysäre Dysostosis. Z Orthop Chir 61: 253-286.
16. Jikko A, Murakami H, Yan W, et al.: 1996. Effects of cyclic adenosine 3′,5′-monophosphate on chondrocyte terminal differentiation and cartilage-matrix calcification. Endocrinology 137:122-128.
17. Jüppner H: 1994. Molecular cloning and characterization of a parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor: a member of an ancient family of G protein-coupled receptors. Curr Opin Nephrol Hypertens 3:371-378.
18. Karaplis AC, Luz A, Glowacki J, et al.: 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289.
19. Kessel D, Hall CM, Shaw DG: 1992. Two unusual cases of nephrocalcinosis in infancy. Pediatr Radiol 22:470-471.
20. Kikuchi S, Hasue M, Watanabe M, Hasebe K: 1976. Metaphysial dysostosis (Jansen type): report of a case with long follow-up. J Bone Joint Surg 58B:102-106.
21. Koike T, Iwamoto M, Shimazu A, Nakashima K, Suzuki F, Kato Y: 1990. Potent mitogenic effects of parathyroid hormone (PTH) on embryonic chick and rabbit chondrocytes: differential effects of age on growth, proteoglycan, and cyclic AMP responses of chondrocytes to PTH. J Clin Invest 85:626-631.
22. Kopp P, van Sande J, Parma J, et al.: 1995. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. New Engl J Med 332:150-154.
23. Kraaij R, Post M, Kremer H, et al.: 1995. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. J Clin Endocrinol Metab 80: 3168-3172.
24. Kronenberg HM, Bringhurst FR, Nussbaum S, et al.: 1993. Parathyroid hormone: biosynthesis, secretion, chemistry, and action. In Mundy GR, Martin TJ, eds. Handbook of Experimental Pharmacology: Physiology and Pharmacology of Bone. Heidelberg, Springer-Verlag, pp 185-201.
25. Kruse K, Schütz C: 1993. Calcium metabolism in the Jansen type of metaphyseal dysplasia. Eur J Pediatr 152:912-915.
26. Lanske B, Karaplis AC, Luz A, Mulligan RC, Kronenberg HM: 1994. Characterization of mice homozygous for the PTH/PTHrP receptor gene null mutation. J Bone Miner Res 9(Suppl 1):S121.
27. Latronico AC, Anasti J, Arnhold IJP, Mendonca BB, Domenice S, Albano MC, et al.: 1995. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 80:2490-2494.
28. Lebovitz HE, Eisenbarth GS: 1975. Hormonal regulation of cartilage growth and metabolism. Vitam Horm 33:575-648.
29. Lee K, Deeds JD, Chiba S, Un-no M, Bond AT, Segre GV: 1994. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134:441-450.
30. Lee K, Deeds JD, Segre GV: 1995. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acid during fetal development of rats. Endocrinology 136:453-463.
31. Lenz WD: 1969. Skeletal dysplasias. In Bergsma D, ed. Proceedings of the First Conference on the Clinical Delineation of Birth Defects, V, No. 4, The Johns Hopkins Hospital. Baltimore, MD: The National Foundation-March of Dimes, pp 71-72.
32. Parma J, Duprez L, Van Sande J, et al.: 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651.
33. Paschke R, Tonacchera M, van Sande J, Parma J, Vassart G: 1994. Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789.
34. 2+-sensing receptor gene mutation. Nature Genet 8:303-307.
35. Rao DS, Frame B, Reynolds WA, Parfitt AM: 1979. Hypercalcemia in metaphyseal chondrodysplasia of Jansen (MCD): an enigma. In Norman AW, Schaefer K, von Herrath D, et al., eds. Vitamin D, Basic Research and Its Clinical Application. Berlin, Walter de Gruyter, pp 1173-1176.
36. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD: 1992. Constitutively active mutants of rhodopsin. Neuron 9:719-725.
37. Schipani E, Karga H, Karaplis AC, et al.: 1993. Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology 132:2157-2165.
38. Schipani E, Kruse K, Jüppner H: 1995a. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100.
39. Schipani E, Weinstein LS, Bergwitz C, et al.: 1995b. Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 80:1611-1621.
40. Shenker A, Laue L, Kosugi S, Merendino JJ Jr., Minegishi T, Cutler GB: 993. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654.
41. Silverthorn KG, Houston CS, Duncan BP: 1983. Murk Jansen's metaphyseal chondrodysplasia with long-term followup. Pediatr Radiol 17:119-123.
42. Smith DM, Roth LM, Johnston CC Jr: 1976. Hormonal responsiveness of adenylate cyclase activity in cartilage. Endocrinology 98: 242-246.
43. Takano T, Takigawa M, Shirai E, Suzuki F, Rosenblatt M: 1985. Effects of synthetic analogs and fragments of bovine parathyroid hormone on adenosine 3′,5′-monophosphate level, ornithine decarboxylase activity, and glycosaminoglycan synthesis in rabbit costal chondrocytes in culture: structure-activity relations. Endocrinology 116:2536-2542.
44. Tian J, Smorgorzewski M, Kedes L, Massry SG: 1993. Parathyroid hormone-parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. Am J Nephrol 13:210-213.
45. Tonacchera M, van Sande J, Cetani F, et al.: 1996. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554.
46. Urena P, Kong XF, Abou-Samra AB, et al.: 1993. Parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA are widely distributed in rat tissues. Endocrinology 133:617-623.
47. Usdin TB, Gruber C, Bonner TI: 1995. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270: 15,455-15,458.
48. Weir E, Philbrick W, Neff L, Amling M, Baron R, Broadus A: 1995. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes skeletal dysplasia and delayed osteogenesis. J Bone Miner Res 10(Suppl 1):S157.